SiteOne Landscape Supply Inc

SiteOne Landscape Supply’s Q4 2025 earnings show steady revenue growth, improved margins, and analysts lifting targets as the company plans significant EBITDA expansion for FY26.

SiteOne Landscape Supply Inc. reported lower-than-expected earnings for Q2 2025, but reaffirmed its full-year 2025 outlook, citing confidence in its long-term strategy.

Eli Lilly has acquired SiteOne Therapeutics for up to $1 billion to bolster its pain management portfolio and expand its non-opioid treatment options.

SiteOne Landscape Supply Inc. is set to release its Q1 2025 earnings on April 30, 2025, with analysts projecting a slight decrease in earnings per share and a 3.09% increase in revenue.